Executive Director, Global Marketing, PDAC Cancer Strategy & Ops

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity

We are hiring an Executive Director of Global Commercial Development, reporting to VP Pancreatic Cancers. The role will work within a growing and fluid Global Commercial Development organization. Roles will continuously evolve as the team grows and portfolio priorities shift across multiple indications and assets. The role will have 2-3 direct reports. This position can be based out of Redwood City (CA), Plainsboro (NJ) or remote.

Responsibilities often include:

- Disease Area Strategy (DAS): Partner with clinical, commercial, medical, access and others to ensure DAS evolves and priorities shift based on latest evidence (internal, competitive). Support prioritization of future assets for development, in-licensing, or combinations. Partner with BD. Be an integrator and conduit of sharing commercial and clinical insights across functions.

- Multi-year Global Commercialization Plan: Partner and lead with Medical and Market Access to build goals, track goals, and refresh the multi-year commercialization plan for pancreatic cancer that cuts across assets and indications. Share learnings with Lung and CRC teams and coordinate to provide input into cross-tumor plan as well.

- Enable Brand Pan-Tumor Strategic Elements: Partner with Pancreatic cancer and other tumor commercial and medical teams to align and deliver strategic elements that should be consistent across indications (e.g., overarching positioning, global brand campaign, brand book, consistent dosing/MOA messages). Increase communication and collaboration across multiple teams. Strengthen communication and collaboration across teams and ensure shared strategic elements are implemented consistently.

- KOL Coordination: Lead global thought leader strategy and coordination: Lead the Senior Director, Global Thought Leader Strategy & Engagement for pancreatic cancers. Guide the development of a strategic approach to global thought leader engagement across the portfolio, coordinate external engagement priorities and relationships, and ensure insights from these interactions inform disease area and commercial strategies. Lead Senior Director, Global Thought Leader Strategy & Engagement for pancreatic cancers, will serve as the strategic architect for global thought leader engagement across the portfolio and coordinate external relationships.

- Operational Excellence: Operating in a build-while-scaling environment, this leader will help shape how complex, cross-functional work gets done - bringing clarity, structure, and momentum while partnering closely with senior leaders. Support team meetings for Pancreatic Cancer GCD teams to ensure well-prepared, broad input, and seamless. Plan team building initiatives to build a strong culture. Build team culture, communications, and efficiency. Drive coordinated annual planning processes (e.g., brand planning, forecast updates) for Pancreatic cancers.

- Lead Pancreatic Cancer teammate providing into early development: Lead director or senior director who coordinates pancreatic commercial input to feed into the early development commercial team. Attend early asset meetings on agenda-driven basis.

-